Lowenstein Reps BASF In Deal For Biotech Co. Verenium

Law360, New York (September 20, 2013, 4:30 PM ET) -- Chemical company BASF Corp. will acquire industrial biotechnology company Verenium Corp., which serves the global food and fuel industries, for about $4 per share, the companies said Friday.

Verenium has about 12.8 million shares outstanding, which would value the deal at about $51 million. The deal is expected to close in the fourth quarter of 2013. The acquisition will bolster BASF’s role in the efficient enzyme space, according to a statement issued by BASF.

“Combining Verenium’s scientific and technological excellence with BASF’s enzyme activities and its...
To view the full article, register now.